Psoriasis drug could slow type 1 diabetes progression in new trial
NCT ID NCT04589325
First seen Apr 30, 2026 · Last updated Jun 18, 2026 · Updated 10 times
Summary
This study tests whether ixekizumab, a drug already approved for psoriasis, can help people newly diagnosed with type 1 diabetes keep making some of their own insulin. About 127 adults aged 18-45 who were diagnosed within the last 100 days will receive either the drug or a placebo for 52 weeks. The main goal is to see if the drug slows the loss of insulin-producing cells, potentially reducing the amount of insulin injections needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE1 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centrum för Diabetes,
Stockholm, Sweden
-
Falu Lasarett
Falun, Sweden
-
Karlstad lasarett
Karlstad, Sweden
-
Kristianstad Hospital
Kristianstad, Sweden
-
Linköping University Hospital
Linköping, Sweden
-
Lund University Hospital
Lund, Sweden
-
Länssjukhuset Ryhov
Jönköping, Sweden
-
NU-Hospital Group
Uddevalla, Sweden
-
Sahlgrenska University Hospital, Sahlgrenska
Gothenburg, Sweden
-
Sahlgrenska University Hospital, Östra Hospital
Gothenburg, Sweden
-
Skaraborgs sjukhus
Skövde, Sweden
-
Södersjukhuset Hospital
Stockholm, Sweden
-
Södra Älvsborg Hospital
Borås, Sweden
-
Uppsala Academic Hospital
Uppsala, Sweden
-
Varbergs sjukhus
Varberg, Sweden
-
Vrinnevi Hospital
Norrköping, Sweden
-
Örebro University Hospital
Örebro, Sweden
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.